Home › Kanser sa Tiyan › Michigan

Pag-aaral pangklinika para sa Kanser sa Tiyan sa Michigan

35 pag-aaral para sa Kanser sa Tiyan ang naghahanap ng mga kalahok sa mga site sa Michigan.

Mga Lungsod sa Michigan

Opisyal na teksto ng pag-aaral (English)

The Vanguard Study: Testing a New Way to Screen for Cancer

Henry Ford Cancer Institute-Downriver, Brownstown
Henry Ford Health Center - Brownstown, Brownstown
Henry Ford Health Center - Chesterfield, Chesterfield
at 13 pa

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 45 hanggang 75 · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06995898

A Study to Learn More About How Well Treatment With Sevabertinib (BAY 2927088) Tablets Works and How Safe it is in Participants Who Have a Solid Tumor With Mutations of the Human Epidermal Growth Factor Receptor 2 (HER2)

Profound Research -OMG - TriAtria Cancer Center, Farmington Hills

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT06760819

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health IHA - Obstetrics and Gynecology West Arbor, Ann Arbor
at 50 pa

Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo

Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

MyMichigan Medical Center Gratiot, Alma
MyMichigan Medical Center Alpena, Alpena
Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor
at 68 pa

Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo

Edad 40 hanggang 75 · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT05334069

Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma

Henry Ford Health, Detroit

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 29, 2026 · NCT07700979

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site, North Shores

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2026 · NCT07069712

Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

Research Site, Grand Rapids

Nagre-recruitPhase 2

Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05489211

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

Barbara Ann Karmanos Cancer Institute, Detroit
BAMF Health Inc., Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

Barbara Ann Karmanos Cancer Institute, Detroit
BAMF Health Inc., Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT07213791

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

START Midwest, Grand Rapids

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 22, 2026 · NCT06128551

Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer

START Midwest, Grand Rapids

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT05267626

Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors

Karmanos Cancer Institiute, Detroit

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT06293898

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Grand Rapids

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT07431281

A Phase 1/1b Study of IAM1363 in HER2 Cancers

University of Michigan, Ann Arbor
Henry Ford Cancer Institute, Detroit
START - Midwest Cancer Research Center, Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Set 9, 2026 · NCT06253871

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

Brigitte Harris Cancer Pavilion BHCP, Detroit
START Midwest, LLC, Grand Rapids

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 2, 2026 · NCT07070232

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Grand Rapids

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 19, 2026 · NCT07115043

A Study of MGC026 in Participants With Advanced Solid Tumors

START Midwest, Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT06242470

A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors

Karmanos Cancer Institute, Detroit

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 11, 2026 · NCT05592626

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

University of Michigan Comprehensive Cancer Center Michigan Medicine, Ann Arbor

Nagre-recruitPhase 3

Edad 18 pataas · Lahat ng kasarian · Na-update Ago 10, 2026 · NCT06731478

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Henry Ford Cancer Institute, Detroit

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 29, 2026 · NCT04198766

Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors

Investigative Site #120, Detroit

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 23, 2026 · NCT06974110

A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

Karmanos Cancer Institute, Detroit
Karmanos Cancer Institute, Farmington Hills

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT05208762

A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors

START Midwest, Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 22, 2026 · NCT06131840

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

Henry Ford Health System, Detroit

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 15, 2026 · NCT06657144

Pharmacokinetic Study of Skeletal Muscle Area-based Paclitaxel Infusion in Patients With Cancer

University of Michigan Rogel Cancer Center, Ann Arbor

Nagre-recruitPhase 4

Edad 18 pataas · Kababaihan · Na-update Hul 2, 2026 · NCT05183126

Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan

START Midwest /ID# 248685, Grand Rapids

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 23, 2026 · NCT05005403

Study to Evaluate the Diagnostic Performance of GEH300079 (68Ga) Injection PET/CT for Detection of PC in Patients With Colorectal, Gastric, Ovarian, or Pancreatic Cancers (PERISCOPE)

BAMF Health, Grand Rapids

Nagre-recruitPhase 2/3

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT07219238

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

University of Michigan, Ann Arbor

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Hun 15, 2026 · NCT05768932

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Research Site, Grand Rapids

Nagre-recruitPhase 2

Edad 18 pataas · Lahat ng kasarian · Na-update May 14, 2026 · NCT05702229

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Henry Ford Cancer-Detroit, Detroit

Nagre-recruitPhase 1

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 19, 2025 · NCT06065371

A Study of MT-4561 in Patients With Various Advanced Solid Tumors

START Midwest, Grand Rapids

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Dis 11, 2025 · NCT06943521

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Ann Arbor
Massive Bio SYNERGY-AI site, Lansing

Nagre-recruitObservasyonal na pag-aaral

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

A Study to Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

University of Michigan, Ann Arbor

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Set 24, 2025 · NCT05941507

64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer

BAMF Health, Inc., Grand Rapids

Nagre-recruitPhase 1/2

Edad 15 pataas · Lahat ng kasarian · Na-update Ago 12, 2025 · NCT06298916

A Beta-only IL-2 ImmunoTherapY Study

Karmanos Cancer Institute, Detroit

Nagre-recruitPhase 1/2

Edad 18 pataas · Lahat ng kasarian · Na-update Hul 9, 2025 · NCT05086692

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.